Endothelial injury of capillaries in the stria vascularis of guinea pigs treated with cisplatin and gentamicin

Ultrastructural Pathology

Volumn 21, Issue 3, 1997, Pages 289-299

  Kohn, Sarah ^a   Fradis, Milo ^a,b   Podoshin, Ludwig ^a,b   Ben David, Jacob ^b   Zidan, Jamal ^c   Robinson, Eliezer ^a,c  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b BNAI ZION MEDICAL CENTER   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Cisplatin; Gentamicin; Stria vascularis; Toxicity; Ultrastructure

Indexed keywords

CISPLATIN; GENTAMICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG TOXICITY; ENDOTHELIUM INJURY; GUINEA PIG; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; STRIA VASCULARIS; SUBCUTANEOUS DRUG ADMINISTRATION; ULTRASTRUCTURE;

EID: 0030926862     PISSN: 01913123     EISSN: None     Source Type: Journal    
DOI: 10.3109/01913129709021925     Document Type: Article

References (29)

1. Helson L, Okonkwo E, Anton L, Cvitkovic E. cis-Platinum ototoxicity. Clin Toxicol. 1978;13:469-478.
2. Piel IJ, Meyer D, Perlia CP, Wolfe VI. Effects of cis-diamminedichloroplatinum (NSC-119875) on hearing function in man. Cancer Chemother Rep. 1974;58:871-875.
3. Rybak LP. cis-Platinum associated hearing loss. J Laryngol Otol. 1981;95:745-747.
4. Chapman P. Rapid onset hearing loss after cis-platinum therapy: case reports and literature review. J Laryngol Otol. 1982;96:159-162.
5. Fleischman RW, Stadnicki SW, Ethier MF, Schaeppi U. Ototoxicity of cis-dichlorodiammine platinum(II) in the guinea pig. Toxicol Appl Pharmacol. 1975;33:320-332.
6. Stadnicki SW, Fleischman RW, Schaeppi U, Merriam P. cis-Dichlorodiammineplatinum(II) (NSC-119875): hearing loss and other toxic effects in rhesus monkeys. Cancer Chemother Rep. 1975;59:467-480.
7. Estrem SA, Babin RW, Ryu JH, Moore KC. cis-Diamminedichloroplatinum(II) ototoxicity in the guinea pig. Otolaryngol Head Neck Surg. 1981;89:638-645.
8. Nakai Y, Konishi K, Chang KC, et al. Ototoxicity of the anticancer drug cisplatin: an experimental study. Acta Otolaryngol (Stockh). 1982;93:227-232.
9. Marco-Algarra J, Basterra J, Marco J. cis-Diaminedichloro platinum ototoxicity: an experimental study. Acta Otolaryngol (Stockh). 1985;99:343-347.
10. Boheim K, Bichler E. Cisplatin-induced ototoxicity: audiometric findings and experimental cochlear pathology. Arch Otorhinolaryngol. 1985;242:1-6.
11. Kohn S, Fradis M, Pratt H, et al. Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis. Laryngoscope. 1988;98:865-871.
12. Keating MJ, Bodey GP, Valdivieso M, Rodriguez V. A randomized comparative trial of three aminoglycosides: comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies. Medicine (Baltimore). 1979;58:159-170.
13. Lerner SA, Matz GJ. Aminoglycoside ototoxicity. Am J Otolaryngol. 1980;1:169-179.
14. Huizing EH, de Groot JCMJ. Human cochlear pathology in aminoglycoside ototoxicity: a review. Acta Otolaryngol Suppl (Stockh). 1987;436:117-125.
15. Schweitzer VG, Hawkins JE, Lilly DJ, et al. Ototoxic and nephrotoxic effects of combined treatment with cis-diamminedichloroplatinum and kanamycin in the guinea pig. Otolaryngol Head Neck Surg. 1984;92:38-49.
16. Kohn S, Fradis M, Podoshin L, et al. Toxic effects of cisplatin alone and in combination with gentamicin in stria vascularis of guinea pigs. Laryngoscope. 1991;101:709-716.
17. Kimura RS, Ota CY. Ultrastructure of toe cochlear blood vessels. Acta Otolaryngol (Stockh). 1974;77:231-250.
18. İçli F, Karaoǧuz H, Dinçol D, et al. Severe vascular toxicity associated with cisplatin-based chemotherapy. Cancer. 1993;72:587-593.
19. Doll DC, Yarbro JW. Vascular toxicity associated with antineoplastic agents. Semin Oncol. 1992;19:580-596.
20. Doll DC, Yarbro JW. Vascular toxicity associated with chemotherapy and hormonotherapy. Curr Opinion Oncol. 1994;6:345-350.
21. Gratacap B, Charachon R, Stoebner P. Results of an ultrastructural study comparing stria vascularis with organ of Corti in guinea pigs treated with kanamycin. Acta Otolaryngol (Stockh). 1985;99:339-342.
22. Gordon JA, Gattone VH 2d. Mitochondrial alterations in cisplatin-induced acute renal failure. Am J Physiol. 1986; 250:F991-F998.
23. Ghadially FN. Ultrastructural Pathology of the Cell: A Text and Atlas of Physiological and Pathological Alterations in Cell Fine Structure. London: Butterworth; 1975:170-173.
24. Vogelzang NJ, Torkelson JL, Kennedy BJ. Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin. Cancer. 1985;56:2765-2770.
25. Lazo JS. Endothelial injury caused by antineoplastic agents. Biochem Pharmacol. 1986;35:1919-1923.
26. Saito T, Aran J-M. Comparative ototoxicity of cisplatin during acute and chronic treatment. ORL J Otorhinolaryngol Relat Spec. 1994;56:315-320.
27. Waters GS, Ahmad M, Katsarkas A, Stanimir G, McKay J. Ototoxicity due to cis-diamminedichloroplatinum in the treatment of ovarian cancer: influence of dosage and schedule of administration. Ear Hear. 1991;12:91-102.
28. Saito T, Yamada T, Manabe Y, Yamamoto T, Saito H. Cisplatin metabolites and their toxicity on isolated cochlear outer hair cells in vitro. Acta Otolaryngol (Stockh). 1996; 116:561-565.
29. Huang MY, Schacht J. Formation of a cytotoxic metabolite from gentamicin by liver. Biochem Pharmacol. 1990;40: R11-R14.